Mechanically, the abundance of PD-L1 on melanoma EVs is raised by IFN-γ, and EVs-PD-L1 chiefly targets PD-1+ CD8 T cells and promotes tumor growth in vivo. This evidence concerns the gene IFNG and melanoma.